Statin Use and Risk of Cognitive Decline in the ADNI Cohort

HMG-CoA reductase inhibitors (statins) have been proposed to both positively and negatively alter the cognitive trajectory of older adults. To further investigate the disparate findings (provided by the FDA black box warning, adverse event reports, case-control studies, observational studies, and ra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Geriatr Psychiatry
Autores principales: Kemp, Emily C., Ebner, Megan K., Ramanan, Srinath, Godek, Tyler A., Pugh, Erika A., Bartlett, Hugh H., McDonald, Julia W., Mecca, Marcia C., van Dyck, Christopher H., Mecca, Adam P.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170771/
https://ncbi.nlm.nih.gov/pubmed/31806426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jagp.2019.11.003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares